Echinocandin Antifungal [EPC]

8210 reported adverse events

Drugs of this class: ANIDULAFUNGIN MICAFUNGIN MICAFUNGIN SODIUM REZAFUNGIN

These side effects are most commonly reported by patients taking drugs of the Echinocandin Antifungal [EPC] class:

# Side effect Count
0 DRUG INEFFECTIVE 1486
1 OFF LABEL USE 902
2 PYREXIA 580
3 FEBRILE NEUTROPENIA 482
4 MULTIPLE ORGAN DYSFUNCTION SYNDROME 431
5 SEPSIS 427
6 PNEUMONIA 388
7 PRODUCT USE IN UNAPPROVED INDICATION 362
8 SEPTIC SHOCK 356
9 NEUTROPENIA 322
See all common reactions for Echinocandin Antifungal [EPC]

Drugs of the Echinocandin Antifungal [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PRE-ENGRAFTMENT IMMUNE REACTION 44 0.5500
1 GEOTRICHUM INFECTION 51 0.2417
2 TRICHOSPORON INFECTION 46 0.1136
3 DISSEMINATED MUCORMYCOSIS 44 0.1117
4 PULMONARY MUCORMYCOSIS 52 0.0985
5 FUSARIUM INFECTION 68 0.0971
6 SCEDOSPORIUM INFECTION 60 0.0850
7 FUNGAEMIA 107 0.0679
8 CEREBRAL ASPERGILLOSIS 40 0.0650
9 SYSTEMIC MYCOSIS 61 0.0522
See all enriched reactions for Echinocandin Antifungal [EPC]